Literature DB >> 32342457

Exercise and Coronary Heart Disease.

Aydin Akyuz1.   

Abstract

Coronary artery disease (CAD) can be obstructive or nonobstructive. Patients with nonobstructive and stable angina pectoris are usually women. Nonobstructive CAD is caused by endothelial dysfunction at the microvascular level, such as cardiac syndrome X and coronary slow flow syndrome. Even if coronary anatomy is nonobstructive, the presence of myocardial ischemia is a major determinant for the exercise program. CAD is a chronic inflammatory disease, and the progression of the disease can lead to a rapid change in the functional capacity of CAD patients. Exercise training is a major component of cardiac rehabilitation and reduces cardiovascular mortality, morbidity, and rehospitalization as well as improves psychological stress and controls risk factors of CAD, such as diabetes mellitus, hypertension, and obesity. It is possible that the quality of life of patients with CAD can be improved by using appropriate exercise therapy. However, the exercise programs among CAD patients are highly underutilized. This chapter will summarize the research progress of exercise in the prevention and treatment of CAD as well as how to create safe exercise programs and the importance of exercise for patients with CAD. In addition, exercise training has fundamental beneficial effects on ischemic and nonischemic heart failure.

Entities:  

Keywords:  Coronary heart disease; Dynamic exercise; Static exercise

Mesh:

Year:  2020        PMID: 32342457     DOI: 10.1007/978-981-15-1792-1_11

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


  5 in total

1.  SIRT1 is Required for Exercise-Induced Beneficial Effects on Myocardial Ischemia/Reperfusion Injury.

Authors:  Dawei Wang; Hongyan Cao; Xu Wang; Jinchun Wang; Manli Wang; Jian Zhang; Lin Wang
Journal:  J Inflamm Res       Date:  2021-04-07

2.  Circulating Levels of IL-13, TGF-β1, and Periostin as Potential Biomarker for Coronary Artery Disease with Acute Heart Failure.

Authors:  Xuan Qiu; Fengyi Ma; Huanxin Zhang
Journal:  Evid Based Complement Alternat Med       Date:  2021-10-08       Impact factor: 2.629

3.  Protective effect of liquiritin on coronary heart disease through regulating the proliferation of human vascular smooth muscle cells via upregulation of sirtuin1.

Authors:  Liang Yuan; Dajie Wang; Chunyang Wu
Journal:  Bioengineered       Date:  2022-02       Impact factor: 3.269

4.  Updated Meta-Analysis Assessing Effects of Baduanjin on Cardiopulmonary Functions of Patients with Coronary Heart Disease.

Authors:  Dongsheng Wang; Jun Xu
Journal:  Evid Based Complement Alternat Med       Date:  2022-09-29       Impact factor: 2.650

5.  Feasibility and impact of whole-body high-intensity interval training in patients with stable coronary artery disease: a randomised controlled trial.

Authors:  Jacobina Kristiansen; Tórur Sjúrðarson; Erik Lerkevang Grove; Jan Rasmussen; Steen Dalby Kristensen; Anne-Mette Hvas; Magni Mohr
Journal:  Sci Rep       Date:  2022-10-14       Impact factor: 4.996

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.